Brief: VYNE Therapeutics Inc. Q2 Basic EPS USD -3.09

YARROW BIOSCIENCE

14/08/2023 14:11

Aug 14 (Reuters) - VYNE Therapeutics Inc. Q2 net income USD -10.058 million.
* Q2 adjusted net income USD -9.182 million
* Q2 revenue USD 135 thousand
* Q2 EPS from cont ops USD -3.08
* Q2 basic EPS USD -3.09